Heron Therapeutics
HRTX
HRTX
167 hedge funds and large institutions have $126M invested in Heron Therapeutics in 2026 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 52 increasing their positions, 43 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
39% less capital invested
Capital invested by funds: $207M → $126M (-$81.2M)
47% less call options, than puts
Call options by funds: $904K | Put options by funds: $1.71M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
167
Holding in Top 10
1
Calls
$904K
Puts
$1.71M
Top Buyers
| 1 | +$11.4M | |
| 2 | +$1.44M | |
| 3 | +$1.4M | |
| 4 |
CPC
Congress Park Capital
Saratoga Springs,
New York
|
+$1.12M |
| 5 |
RB
Richmond Brothers
Jackson,
Michigan
|
+$1M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$1.59M | |
| 3 | -$1.55M | |
| 4 |
Two Sigma Investments
New York
|
-$790K |
| 5 |
Morgan Stanley
New York
|
-$522K |
